Cargando…
Recent advances in epigenetic anticancer therapeutics and future perspectives
Tumor development is frequently accompanied by abnormal expression of multiple genomic genes, which can be broadly viewed as decreased expression of tumor suppressor genes and upregulated expression of oncogenes. In this process, epigenetic regulation plays an essential role in the regulation of gen...
Autores principales: | Ren, Liwen, Yang, Yihui, Li, Wan, Yang, Hong, Zhang, Yizhi, Ge, Binbin, Zhang, Sen, Du, Guanhua, Wang, Jinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845602/ https://www.ncbi.nlm.nih.gov/pubmed/36685834 http://dx.doi.org/10.3389/fgene.2022.1085391 |
Ejemplares similares
-
CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis
por: Ren, Liwen, et al.
Publicado: (2022) -
Progress on diagnostic and prognostic markers of pancreatic cancer
por: YANG, HONG, et al.
Publicado: (2023) -
Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB /IL-6/STAT3 and JNK/PTX3 pathways
por: Li, Wan, et al.
Publicado: (2022) -
Epigenetic Reprogramming During Somatic Cell Nuclear Transfer: Recent Progress and Future Directions
por: Wang, Xiangyu, et al.
Publicado: (2020) -
ERCC6L facilitates the onset of mammary neoplasia and promotes the high malignance of breast cancer by accelerating the cell cycle
por: Yang, Hong, et al.
Publicado: (2023)